RecruitingPhase 1 / Phase 2NCT06785636
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Sponsor: Pathos AI, Inc.
Jefferson, LA · +18 more sites
1 recruiting prostate cancer studies with a site in Jefferson, LA.
Sponsor: Pathos AI, Inc.
Jefferson, LA · +18 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.